CSIMarket
 


Sangui Biotech International Inc  (SGBI)
Other Ticker:  
 


Sangui Biotech International Inc's Gross Profit Margin by quarter

Trends, Rankings, Statistics



SGBI Gross Profit Margin (Mar 31 2022)
III. Quarter
(Dec 31 2021)
II. Quarter
(Sep 30 2021)
I. Quarter
(Jun 30 2021)
IV. Quarter
(Mar 31 2021)
III. Quarter
Y / Y Revenue Change -15.24 % 107.37 % -6.64 % 78.72 % 129.96 %
Seq. Revenue Change -19.02 % 19.46 % 34.19 % -34.7 % 98.11 %
Revenue In Millions $0.02 $0.02 $0.02 $0.01 $0.02
Gross Profit Margin - - - - -
Gross Profit Margin Total Ranking # 828 # 866 # 798 # 791 # 722
Gross Profit In Millions $0.02 $0.02 $0.02 $0.01 $0.02
Y / Y Gross Profit Change - - - - -
Seq. Gross Profit Change - - - - -


Commenting Third Quarter 2022 Gross Profit Margin
Sangui Biotech International Inc experienced contraction in Gross Profit by -19.02 % to $0 millions and Revenue by -19.02 %, while Gross Profit Margin fell to 100 %, below company's average Gross Profit Margin.

Observing third quarter 2022 results within Biotechnology & Pharmaceuticals industry 64 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 828, from total ranking in previous quarter at 866.
Learn about Gross Margin
SGBI's Gross Profit Margin third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 65
Healthcare Sector # 212
Overall # 826

Gross Profit Margin Statistics
High Average Low
217.68 % 101.28 % 32.68 %
(Mar 31 2017)   (Jun 30 2017)




Other Gross Profit Margin Profitability Ratios
SGBI's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
SGBI's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for SGBI's Competitors
Gross Profit Margin Profit Margin for Sangui Biotech International Inc's Suppliers
Gross Profit Margin Profit Margin for SGBI's Customers

You may also want to know
SGBI's Annual Growth Rates SGBI's Profitability Ratios SGBI's Asset Turnover Ratio SGBI's Dividend Growth
SGBI's Roe SGBI's Valuation Ratios SGBI's Financial Strength Ratios SGBI's Gross Profit Growth
SGBI's Roa SGBI's Inventory Turnover Ratio SGBI's Growth Rates SGBI's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2022, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginMar 31 2022 MRQ Gross ProfitMar 31 2022 MRQ Revenue
Jasper Therapeutics Inc.  100.00 %$ 4.593 $ 4.593 
Kymera Therapeutics Inc.  100.00 %$ 9.622 $ 9.622 
Iterum Therapeutics Plc  100.00 %$ 5.177 $ 5.177 
Iteos Therapeutics Inc.  100.00 %$ 152.522 $ 152.522 
Century Therapeutics inc.  100.00 %$ 1.058 $ 1.058 
Merus N.v.  100.00 %$ 11.655 $ 11.655 
Nascent Biotech Inc  100.00 %$ 1.000 $ 1.000 
Pluri Inc.  100.00 %$ 0.234 $ 0.234 
Organovo Holdings Inc.  100.00 %$ 1.500 $ 1.500 
Oncternal Therapeutics Inc.  100.00 %$ 0.746 $ 0.746 
Omega Therapeutics Inc.  100.00 %$ 0.268 $ 0.268 
Infinity Pharmaceuticals Inc.  100.00 %$ 0.652 $ 0.652 
Inhibrx Inc.  100.00 %$ 0.929 $ 0.929 
Fusion Pharmaceuticals Inc.  100.00 %$ 0.585 $ 0.585 
Genocea Biosciences Inc   100.00 %$ 0.270 $ 0.270 
Finch Therapeutics Group Inc.  100.00 %$ 0.354 $ 0.354 
Homology Medicines Inc  100.00 %$ 0.802 $ 0.802 
4d Molecular Therapeutics Inc.  100.00 %$ 1.219 $ 1.219 
Greenlight Biosciences Holdings Pbc  100.00 %$ 0.257 $ 0.257 
Gritstone Bio Inc.  100.00 %$ 7.191 $ 7.191 
Inhibikase Therapeutics Inc.  100.00 %$ 0.046 $ 0.046 
Ikena Oncology Inc.  100.00 %$ 3.384 $ 3.384 
Immunitybio inc.  100.00 %$ 0.014 $ 0.014 
G1 Therapeutics Inc.  100.00 %$ 6.902 $ 6.902 
Poseida Therapeutics Inc   100.00 %$ 1.435 $ 1.435 
Protagonist Therapeutics inc.  100.00 %$ 25.722 $ 25.722 
Tscan Therapeutics Inc.  100.00 %$ 3.021 $ 3.021 
Tg Therapeutics inc.  100.00 %$ 2.016 $ 2.016 
Surface Oncology Inc.  100.00 %$ 30.000 $ 30.000 
Scholar Rock Holding Corp  100.00 %$ 33.193 $ 33.193 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HCYT's Profile

Stock Price

HCYT's Financials

Business Description

Fundamentals

Charts & Quotes

HCYT's News

Suppliers

HCYT's Competitors

Customers & Markets

Economic Indicators

HCYT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071